About
Periodic safety update report single assessments (PSUSAs) are single assessments of related periodic safety update reports (PSURs) for active substances contained in medicines authorised in the European Union (EU). A PSUR is a pharmacovigilance report submitted regularly by a marketing-authorisation holder at defined time points following a medicine's authorisation.
Key facts
- Active substance(s) in scope of the PSUSA procedure
- etoposide
- Procedure number
- PSUSA/00001333/202302
Documents
Etoposide : List of nationally authorised medicinal products - PSUSA/00001333/202302
English (EN) (160.66 KB - PDF)
Etoposide : CMDh Scientific conclusions and grounds for variation, amendments to the Product Information and timetable for the implementation - PSUSA/00001333/202302
English (EN) (169.49 KB - PDF)
български (BG) (205 KB - PDF)
español (ES) (171.89 KB - PDF)
čeština (CS) (219.8 KB - PDF)
dansk (DA) (169.8 KB - PDF)
Deutsch (DE) (179.66 KB - PDF)
eesti keel (ET) (165.88 KB - PDF)
ελληνικά (EL) (200.02 KB - PDF)
français (FR) (172.36 KB - PDF)
hrvatski (HR) (206.42 KB - PDF)
íslenska (IS) (172.3 KB - PDF)
Gaeilge (GA) (150.32 KB - PDF)
italiano (IT) (173.38 KB - PDF)
latviešu valoda (LV) (212.46 KB - PDF)
lietuvių kalba (LT) (210.55 KB - PDF)
magyar (HU) (224.19 KB - PDF)
Malti (MT) (212.38 KB - PDF)
Nederlands (NL) (171.09 KB - PDF)
norsk (NO) (169.52 KB - PDF)
polski (PL) (217.62 KB - PDF)
português (PT) (171.83 KB - PDF)
română (RO) (219.79 KB - PDF)
slovenčina (SK) (217.23 KB - PDF)
slovenščina (SL) (207.01 KB - PDF)
Suomi (FI) (166.48 KB - PDF)
svenska (SV) (172.27 KB - PDF)